September 20, 2024 by Osaka Metropolitan University The invasive fungal infection pulmonary aspergillosis is caused by the aspergillus fungus and has been known to occur among patients with COVID-19. Credit: Yukihiro Kaneko, Osaka Metropolitan UniversityAs society learns to live with COVID-19, research on the disease and its complications remains important. Thus, an Osaka Metropolitan University...
September 9, 2024 by Claire Kowalick, University of Texas Health Science Center at San Antonio Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insights. Credit: PLOS ONE (2024). DOI: 10.1371/journal.pone.0307154Ronald Rodriguez, MD, Ph.D., professor of medical education and urology at Joe...
September 3, 2024 by University of Texas at Austin Graphical abstract. Credit: Cell Reports Medicine (2024). DOI: 10.1016/j.xcrm.2024.101668Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly related SARS-like coronaviruses that infect other animals. As part of a new study on hybrid immunity...
September 3, 2024 by Maria Fernanda Ziegler, FAPESP Lung autopsy tissue infected by SARS-CoV-2 with endothelial cells (red), active inflammasome (green) and SARS-CoV-2 RNA (pink), showing that the virus was replicating. Credit: Keyla de SáAccording to an article published in the journal PLOS Pathogens, severe COVID-19 patients can be divided into two distinct groups: those...
By Vijay Kumar MalesuReviewed by Susha Cheriyedath, M.Sc. Uncovering the molecular interactions between fibrin and the SARS-CoV-2 spike protein, researchers pave the way for targeted therapies that could curb the devastating effects of long COVID. Fibrin drives thromboinflammation and neuropathology in COVID-19. Image Credit: Juan Gaertner / Shutterstock In a recent study published in the...
September 4, 2024 by Anna Fagre, Sadie Jane Ryan, The Conversation Pathogen transmission is bidirectional between animals and humans. Credit: Fagre et al. 2022/Ecology Letters, CC BY-NC-NDWhen the World Health Organization declared COVID-19 a pandemic on March 11, 2020, humans had been the only species with reported cases of the disease. While early genetic analyses...
by Nathaniel Weixel – 08/08/24 1:51 PM ET COVID-19 killed far fewer Americans in 2023 than 2022, according to provisional data from the Centers for Disease Control and Prevention (CDC). The percentage of people who died from the disease dropped nearly 69 percent last year, and COVID-19 was listed as the 10th leading cause of...
August 1, 2024 by University of Oxford Prediction of cognitive, psychiatric, and fatigue outcomes at two to three years after COVID-19 by symptom burden at six months. Credit: The Lancet Psychiatry (2024). DOI: 10.1016/S2215-0366(24)00214-1Many people who were hospitalized with COVID-19 continue to have cognitive and psychiatric problems even two to three years post-infection, according to...
Announcing a new article publication for BIO Integration journal. The emergence of infectious diseases, including viral zoonoses, has allowed intensive research into novel therapeutic approaches. Stem cell therapy, mostly using mesenchymal stem cells (MSCs), has garnered significant attention due to the immunomodulatory properties and tissue repair capabilities. MSCs have demonstrated promise in treating severe COVID-19...
JULY 24, 2024 by Maria Fernanda Ziegler, FAPESP Credit: Unsplash/CC0 Public DomainMemory loss and attention deficit are frequent complaints of people who have survived severe COVID-19, but these and other cognitive impairments have also been observed in mild cases more than 18 months after the start of the infection, according to a study by researchers...
